These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7772526)

  • 1. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients.
    Jensen PD; Jensen FT; Christensen T; Ellegaard J
    Br J Haematol; 1995 Apr; 89(4):880-9. PubMed ID: 7772526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spin density projection-assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia.
    Brown GC; Patton WN; Tapp HE; Taylor DJ; St Pierre TG
    Intern Med J; 2012 Sep; 42(9):990-6. PubMed ID: 22647084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine.
    Hoffbrand AV; Gorman A; Laulicht M; Garidi M; Economidou J; Georgipoulou P; Hussain MA; Flynn DM
    Lancet; 1979 May; 1(8123):947-9. PubMed ID: 87616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of iron overload in adults with continuous parenteral desferrioxamine.
    Cooper B; Bunn HF; Propper RD; Nathan DG; Rosenthal DS; Moloney WC
    Am J Med; 1977 Dec; 63(6):958-66. PubMed ID: 605917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac T2*.
    Ha SY; Mok AS; Chu WC; Raskalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
    Hemoglobin; 2009; 33(5):323-31. PubMed ID: 19814678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia.
    Porter JB; Elalfy M; Taher A; Aydinok Y; Lee SH; Sutcharitchan P; El-Ali A; Han J; El-Beshlawy A
    Eur J Haematol; 2017 Mar; 98(3):280-288. PubMed ID: 27859648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new era in iron chelation therapy: the design of optimal, individually adjusted iron chelation therapies for the complete removal of iron overload in thalassemia and other chronically transfused patients.
    Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):332-8. PubMed ID: 19814679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A; Natsiopoulos K; Kleanthous M; Ioannou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM; Friedman DF; Webb J; Kwiatkowski JL
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients.
    Ooi GC; Khong PL; Chan GC; Chan KN; Chan KL; Lam W; Ng I; Ha SY
    Br J Haematol; 2004 Feb; 124(3):385-90. PubMed ID: 14717788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload.
    Franchini M; Gandini G; de Gironcoli M; Vassanelli A; Borgna-Pignatti C; Aprili G
    Blood; 2000 May; 95(9):2776-9. PubMed ID: 10779420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload.
    Jensen PD; Heickendorff L; Pedersen B; Bendix-Hansen K; Jensen FT; Christensen T; Boesen AM; Ellegaard J
    Br J Haematol; 1996 Aug; 94(2):288-99. PubMed ID: 8759889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac function during iron chelation therapy in adult non-thalassaemic patients with transfusional iron overload.
    Jensen PD; Olsen N; Bagger JP; Jensen FT; Christensen T; Ellegaard J
    Eur J Haematol; 1997 Oct; 59(4):221-30. PubMed ID: 9338620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in liver iron in hemodialysis patients with transfusional iron overload by deferoxamine mesylate.
    Mossey RT; Wielopolski L; Bellucci AG; Wilkes BM; Chandra M
    Am J Kidney Dis; 1988 Jul; 12(1):40-4. PubMed ID: 3389353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.
    Jensen PD; Jensen FT; Christensen T; Heickendorff L; Jensen LG; Ellegaard J
    MAGMA; 2001 May; 12(2-3):153-66. PubMed ID: 11390271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combined deferiprone and deferoxamine chelation therapy on iron load indices in beta-thalassemia.
    Tsironi M; Assimakopoulos G; Polonofi K; Rigaki K; Aessopos A
    Hemoglobin; 2008; 32(1-2):29-34. PubMed ID: 18274980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the ferritin/alanine aspartate transaminase ratio as an iron overload marker independent of liver cell damage.
    Triadou P; Regnat-Lusinchi A; Girot R
    Eur J Haematol; 1989 Nov; 43(5):423-7. PubMed ID: 2612615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.